Medpace Clinical Research India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 17 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 62.43%
(FY 2023)
- Profit 112.10%
(FY 2023)
- Ebitda 76.84%
(FY 2023)
- Net Worth 62.86%
(FY 2023)
- Total Assets 169.71%
(FY 2023)
About Medpace Clinical Research India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jesse Geiger, Stephen Ewald, and Preeti Kabra serve as directors at the Company.
- CIN/LLPIN
U24232MH2007PTC338993
- Company No.
160227
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Mar 2007
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Medpace Clinical Research India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Stephen Ewald  | Director | 16-Nov-2020 | Current |
Preeti Kabra  | Director | 26-Apr-2023 | Current |
| Jesse Geiger | Director | 16-Nov-2020 | Current |
Financial Performance of Medpace Clinical Research India.
Medpace Clinical Research India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 62.43% increase. The company also saw a substantial improvement in profitability, with a 112.1% increase in profit. The company's net worth Soared by an impressive increase of 62.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Medpace Clinical Research India?
In 2023, Medpace Clinical Research India had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Medpace Clinical Research India?
Medpace Clinical Research India has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Medpace Clinical Research India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Medpace Clinical Research India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
